Skip to content
★ Sign in to follow
CR

Christine R. Larson

CFO
PDL Biopharma, Inc.
Total declarations
12
Company
1
▲ Purchases (10 ops.)
€70k
▼ Sales (0 ops.)
—

Latest filing published 25 May 2011 for PDL BIOPHARMA, INC..

Insider track record

Disclosed buys
10
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
10

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Christine R. Larson: trading record in brief

Christine R. Larson discloses dealings in PDL Biopharma, Inc. to SEC (Form 4). We count 12 filings; the first trade dates from 2 January 2009 and the latest from 23 May 2011.

On the market, this insider has only ever bought: 10 purchases, €70k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 share grants.

The median purchase comes to €1,858.

Most recently, on 25 May 2011, the filings show a share grant in PDL Biopharma, Inc. The last purchase on record was published on 17 May 2010, which is 6,020 days ago. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Christine R. Larson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total

12 of 12 declarations